AB33. Botox: the novel therapy for OAB
Botulinum toxin has recently been approved by the United States FDA for idiopathic and neurogenic detrusor overactivity (overactive bladder). This is an easy clinic procedure that can be performed cystoscopically under local anesthesia with very good success. We will discuss the mechanism of action...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
AME Publishing Company
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708434/ |